Clinical Trial Update: Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating node-sparing short-course radiotherapy combined with first-line therapy and a PD-1 inhibitor for unresectable or metastatic micr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Immune Checkpoint Therapy, Radiotherapy | Phase 2 | Status: NOT_YET_RECRUITING